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Abstract: Metal oxide nanoparticles (NPs) have a wide variety of applications in many consumer
products and biomedical practices. As a result, human exposure to these nanomaterials is highly
frequent, becoming an issue of concern to public health. Recently, human salivary leucocytes have
been proposed as an adequate non-invasive alternative to peripheral blood leucocytes to evaluate
genotoxicity in vitro. The present study focused on proving the suitability of salivary leucocytes
as a biomatrix in the comet assay for in vitro nanogenotoxicity studies, by testing some of the
metal oxide NPs most frequently present in consumer products, namely, titanium dioxide (TiO2),
zinc oxide (ZnO), and cerium dioxide (CeO2) NPs. Primary and oxidative DNA damage were
evaluated by alkaline and hOGG1-modified comet assay, respectively. Any possible interference of
the NPs with the methodological procedure or the hOGG1 activity was addressed before performing
genotoxicity evaluation. Results obtained showed an increase of both primary and oxidative damage
after NPs treatments. These data support the use of salivary leucocytes as a proper and sensitive
biological sample for in vitro nanogenotoxicity studies, and contribute to increase the knowledge on
the impact of metal oxide NPs on human health, reinforcing the need for a specific regulation of the
nanomaterials use.
Keywords: TiO2 nanoparticles; ZnO nanoparticles; CeO2 nanoparticles; salivary leukocytes; comet
assay; interference; genotoxicity
1. Introduction
The fast development of the nanotechnology industry has resulted in a growing pub-
lic debate on the possible health impact of the new engineered nanoproducts. Together
with the direct exposure of subjects involved in nanomaterial manufacturing processes
or patients subjected to nanomedical procedures and/or treatments, these new products
can be released into the environment and appear in water, air, and soil, becoming envi-
ronmental pollutants and entailing a potential threat for both humans and ecosystems [1].
Consequently, the risk assessment of nanomaterials entering the environment and present
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in workplaces is becoming an increasingly important issue for governments, regulatory
authorities, and international organizations that work in developing policy frameworks
and guidance documents related to nanotechnology and nanosafety [2,3]. A key advance
on this topic has been recently made to provide clear guidance on aquatic toxicity testing of
manufactured nanomaterials using OECD methods [4]. Still, despite this common global
effort, there is an important lack of toxicological information that makes it difficult to
move forward in these policies [3,5]. A deep understanding of the toxicological profile of
these novel engineered nanomaterials is necessary in order to develop a proper regulatory
context ensuring that these compounds are safe for use and are produced responsibly, with
optimization of benefits and minimization of risks. The lack of adequate detection and
characterization techniques and of reproducible and validated methods for toxicological
assessment of nanomaterials have been identified as major bottlenecks for the safe and
sustainable use of nanomaterials [6].
Metal-based is one of the five categories in which nanomaterials are classified, and in-
cludes metal(loid) oxides [7]. These are chemical compounds that contain at least one metal
atom and one or more oxygen atoms. Among nanomaterials, metal oxide nanoparticles
(NPs) have received considerable attention largely due to their variety of uses, namely in
optics and electronics, healthcare, construction, automotive and personal care products [8].
Due to this wide diversity of applications, they are commonly present in many consumer
products and biomedical practices [8,9]. As a result, human exposure to metal oxide NPs is
highly frequent, becoming a matter of special concern for public health in the last years.
Due to the well-established link between DNA alterations and many pathologies
and health conditions, genotoxicity of nanomaterials and, in particular, of metal oxide
NPs, becomes an important issue that needs to be addressed and investigated providing
data crucial for a complete risk assessment of these materials before mass production.
However, while the acute toxicity of nanomaterials has been relatively widely evaluated,
their genotoxicity has been less studied and the available information is still limited [10].
Together with the micronucleus test and the Ames test, the comet assay is the most
frequently used approach for nanogenotoxicity evaluation [11]. The comet assay, also
known as the single-cell gel electrophoresis assay, is a method for measuring DNA strand
breaks in eukaryotic individual cells. Protocol variants also allow the specific evaluation
of oxidative DNA damage, DNA methylation or DNA repair alterations, among other
genetic insults [12]. Due to this versatility, together with its simplicity and sensitivity, this
technique has been extensively employed in in vitro, in vivo and in human population
studies using a number of different cell systems and biomatrices. Still, the most common
human primary cell type used for in vitro studies and for biomonitoring studies are, by far,
leucocytes collected from peripheral blood.
Recently, human salivary leucocytes have been proposed as a non-invasive adequate
alternative to peripheral blood leucocytes to evaluate the genotoxic effects of recent ex-
posure to environmental contaminants, particularly those involving inhalatory or oral
exposure routes [13]. Moreover, this cell type might be also useful for in vitro testing, and
indeed our group has recently proved that leucocytes isolated from saliva samples, both
fresh and cryopreserved, can be employed as appropriate biomatrices to detect primary
and oxidative DNA damage caused by different mechanisms by the comet assay [14]. How-
ever, their suitability and the specific protocol to be employed for in vitro nanogenotoxicity
screening have not been described yet.
On this basis, the present study focused on proving the suitability of human salivary
leucocytes to be employed as biomatrix in the comet assay for in vitro nanogenotoxicity
studies, by evaluating the potential genotoxicity of some of the metal oxide NPs most
frequently present in consumer products, namely titanium dioxide (TiO2), zinc oxide (ZnO),
and cerium dioxide (CeO2) NPs. Both primary and oxidative DNA damage evaluation
were addressed by means of the alkaline standard and hOGG1-modified versions of the
comet assay, respectively, previously checking the possible interference of the NPs with
these procedures.
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2. Materials and Methods
2.1. Chemicals
Titanium dioxide nanoparticles (TiO2 NPs) (rutile:anatase 15:85) (CAS No. 13463-67-7)
was purchased from Degussa-Evonik (Bitterfeld, Germany). Zinc oxide nanoparticles (ZnO
NPs) (CAS No. 1314-13-2), cerium dioxide nanoparticles (CeO2 NPs) (CAS No. 1306-38-3),
dimethyl sulfoxide (DMSO) ACS reagent ≥99.9% (CAS number 67-68-5), Histopaque®-
1077 sterile-filtered, methyl methanesulfonate (MMS) 99% (CAS number 66-27-3), potas-
sium bromate (KBrO3) for analysis EMSURE® Reag. Ph Eur (CAS number 7758-01-2),
4′,6-diamidine-2′-phenylindole (DAPI) (CAS No. 28718-90-3), and trypan blue (CAS No.
72-57-1) were purchased from Sigma-Aldrich Co (Madrid, Spain). Human 8-oxoguanine
DNA glycosylase (hOGG1) was obtained from Trevigen Inc (Gaithersburg, MD, USA).
MMS and KBrO3 were dissolved in sterile distilled water (dH2O).
2.2. Nanoparticle Suspensions: Preparation and Characterization
TiO2, ZnO and CeO2 NPs were suspended in either deionized water or leucocyte
culture medium [RPMI 1640 medium containing 15% fetal bovine serum (FBS), 1% L-
glutamine (200 mM), and 1% penicillin (5000 U/mL)/streptomycin (5000 µg/mL) (all from
Gibco, Thermo Fisher Scientific Inc., Uppsala, Sweden)] at final concentrations of 150, 40
and 10 µg/mL, respectively, and ultrasonicated with a 2.5 mm probe (Sonoplus mini 20,
Bandelin, Berlin, Germany) at 30 W for 5 min (0.5 min on and 1 min off twice, plus 2 min
on). Three independent replicates of each suspension were performed. To avoid heating of
the NPs suspensions, they were maintained in ice during the whole sonication procedure.
Dynamic Light Scattering (DLS) and zeta potential measurements were performed with a
Zetasizer Nano-ZS (Model ZEN 3600, Malvern Instruments, Worcestershire, UK), equipped
with 4.0 mW 633 nm He-Ne laser. The DLS and laser Doppler velocimetry (LDV) were
used for characterization of hydrodynamic diameter and charge (zeta potential) of the
NPs, respectively.
2.3. Sample Collection and Processing
Saliva samples were obtained from 6 non-smoking healthy volunteers (3 women and
3 men, aged between 18 and 53). This study followed ethical criteria established by the
Helsinki declaration and was approved by the University of A Coruña Ethics Committee
(2021-0027). Prior to joining the study, each donor signed an informed consent. Donors
were asked not to eat or drink anything but water in the hour preceding sampling. Saliva
samples were collected from each subject by performing four consecutive mouth rinses
(1 min each) with 10 mL of 0.9% NaCl sterile solution. The four rinses were combined
in sterile 50 mL centrifuge tubes and centrifuged for 15 min at 1100× g and 4 ◦C. The
supernatants were discarded, and cell pellets were re-suspended in 2 mL phosphate-
buffered saline solution (PBS).
A pool was prepared combining cell suspensions from all donors in order to avoid
results modifications due to interindividual variability; it was centrifuged for 15 min at
4 ◦C and 1100× g, and the cell pellet was re-suspended in 8 mL RPMI 1640 medium.
Leucocytes were then isolated by density gradient centrifugation using Histopaque®-1077
(Sigma-Aldrich Co, Madrid, Spain), according to the manufacturer’s guidelines. In brief,
cell suspension was carefully layered over 4 mL Histopaque®-1077, and centrifuged at
400× g for 30 min with brake turned off. The interface containing the leucocytes was
collected and transferred to another tube with 5 mL PBS, and centrifuged for 15 min at
1100× g. The cell pellet was re-suspended at 2.5 × 106 cells/mL in freezing medium [40%
RPMI 1640, 50% FBS, and 10% DMSO], aliquoted into cryogenic vials, and stored at−80 ◦C
for at least one week.
Additionally, a positive reference standard was prepared with salivary leucocytes
obtained from the same six donors. The purpose of this reference standard was to control
for interassay variability in the comet assay. Samples were collected and leucocytes were
isolated as described above. After pooling all cell suspensions and centrifuging for 15 min
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at 1100× g, leucocytes were re-suspended at 1.56 × 106 cells/mL in culture medium
and treated with 50 µg/mL MMS (1% of final volume) for 3 h at 37 ◦C. Then, cells were
centrifuged again, suspended in freezing medium, aliquoted at 1.3 × 105 cells/mL into
cryogenic vials, and stored at −80 ◦C. Leucocytes from one aliquot were used as reference
standard in each experiment conducted.
2.4. Treatments
Frozen saliva leucocytes were quickly thawed at 37 ◦C, centrifuged at 1100× g for
15 min, and washed again with PBS. Aliquots containing 6.6 × 104 cells/mL were treated
at 37 ◦C for 3 h in culture medium containing each of the NPs at three different concen-
trations: 80, 120 and 150 µg/mL TiO2 NPs; 20, 30 and 40 µg/mL ZnO NPs, and 0.5, 2 and
10 µg/mL CeO2 NPs. The doses and treatment time were selected on the basis of previous
studies [15–17]. Negative controls (culture medium) were included in each experiment.
Positive controls used were 50 µg/mL MMS for 3 h in the case of primary DNA damage,
and 335 µg/mL KBrO3 for 1 h in the case of oxidative DNA damage [14]. Trypan blue
exclusion technique was used to assess cell viability after treatments. Thus, cells were
centrifuged at 1100× g for 5 min, resuspended in 500 µL PBS, and 20 µL of the cell sus-
pension was then mixed with 20 µL of 0.4% trypan blue solution. The number of trypan
blue positive cells (not viable) was measured using a Neubauer cell counting chamber at a
Nikon HFX-DX light microscope (Tokyo, Japan). Cell viability was determined as follows:
%viability = 100 − [(number of dead cells/total number of cells counted) × 100], resulting
higher than 80% in all cases.
2.5. Alkaline Comet Assay
Comet assay was described in this manuscript according to the Minimum Information
for Reporting Comet Assay procedures and results (MIRCA) recommendations [18]. Pri-
mary DNA damage, i.e., single and double strand breaks, and alkali-labile sites, induced in
salivary leucocytes by NPs exposure, was evaluated by the standard alkaline comet assay.
At the end of the NPs treatments, cells were centrifuged for 3 min at 8700× g. Supernatant
was removed, and 20 µL of the remaining cell suspension were mixed with 80 µL of freshly
made 0.9% low-melting-point (LMP) agarose (final agarose concentration 0.72%). Two
drops of 40 µL each of this suspension were placed on a slide previously coated with a layer
of 1% normal-melting-point agarose, and covered with 20 × 20 mm coverslips. Agarose
solidification was allowed for 15 min placing the slides on ice. Then, the coverslips were
removed and the slides were immersed in lysis solution (250 mM NaOH, 10 mM Tris-HCl,
100 mM Na2EDTA, 2.5 M NaCl, pH 10, and 1% Triton X-100 added just before use) at 4 ◦C
overnight in the dark to avoid additional DNA damage due to laboratory light conditions
when handling photosensitizing compounds such as TiO2 [19]. After lysis, slides were
placed on a horizontal electrophoresis tank in an ice bath, and incubated for 20 min in the
dark in freshly prepared alkaline electrophoresis solution (300 mM NaOH, 1 mM Na2EDTA,
pH > 13) for DNA unwinding. Electrophoresis was then conducted for 20 min at 0.83 V/cm.
Slides were washed three times (5 min each) with neutralizing solution (0.4 M Tris–HCl,
pH 7.5), and air-dried at room temperature in the dark. Preparations were stained with
25 µL of 5 µg/mL DAPI per drop, for at least 30 min before scoring. Slides were stored in
a humidified sealed box at 4 ◦C to prevent drying of the gel. They were analyzed within
six days.
Comet IV software (Perceptive Instruments, Suffolk, UK) was used for image capture
and analysis. Fifty cells per drop (100 from each slide) were scored “blindly” by the same
scorer using a magnification of 40×. Percentage of DNA in the comet tail (%tDNA) was
used as a DNA damage parameter.
Positive reference standards (assay controls) were used in all experiments in order to
correct sample data for experimental variation. The correction factor for normalization was
calculated according to Collins et al. [20]. In all experiments, this correction factor ranged
between 0.98 and 1.05.
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Additionally, prior to conducting the comet assay experiments, the possible interfer-
ence of the NPs with the comet assay protocol was tested following Magdolenova et al. [21].
Briefly, after thawing, leucocytes were centrifuged for 3 min at 8700× g, supernatant was
removed, and 20 µL of the cell suspension were mixed with 40 µL of 1.8% LMP agarose
and 40 µL of each NPs so that their final concentration was the highest tested in this study
(150, 40, and 10 µg/mL for TiO2, ZnO and CeO2 NPs, respectively). Two drops of 40 µL
each of this suspension were used to prepare a slide. Then, the alkaline comet assay was
performed according to the general protocol described above. Results obtained for each
type of NPs were compared with a negative control (leucocytes without NPs).
2.6. hOGG1-Modified Comet Assay
In order to evaluate oxidative DNA damage, the hOGG1-modified comet assay was
conducted at the end of NPs treatments. Duplicate slides were prepared for each ex-
perimental condition (two agarose drops per slide). After the lysis step in the standard
alkaline comet assay, slides were washed with enzyme buffer (0.1 M KCl, 0.5 mM EDTA,
40 mM Hepes, 0.2 mg/mL bovine serum albumin, pH 8.0) 3 times for 5 min each. One
of the slides from each condition was treated with 50 µL hOGG1 (0.0016 U/µL buffer),
and the other slide was treated with just 50 µL of enzyme buffer. Coverslips were placed
on top of each drop, and slides were incubated at 37 ◦C for 10 min in a humidified box.
Slides were then processed as in the standard alkaline comet assay described above. Net
hOGG1-sensitive sites were calculated for each experimental condition by subtracting the
%tDNA corresponding to the buffer incubation from that corresponding to the enzyme
incubation. All experiments included positive reference standards; normalization was
conducted following Collins et al. [20].
Possible interference of the NPs with hOGG1 enzyme activity was tested previous
to the hOGG1-modified comet assay experiments, according to the indications of Mag-
dolenova et al. [21]. In brief, leucocytes were incubated for 1 h either with 335 µg/mL
KBrO3 plus each NPs at the highest concentration tested, or with just KBrO3. Then,
hOGG1-modified comet assay was performed as described above. Results obtained for
each type of NPs+KBrO3 and for KBrO3 were compared with a negative control (cells
without any treatment).
2.7. Statistical Analysis
Experimental data were expressed as mean ± standard error. Three independent
experiments were carried out for each experimental condition tested, and each condition
was always run in duplicate. Kruskal–Wallis test and Mann–Whitney U-test were used to
analyze differences among groups (all concentrations tested under the same conditions)
and two-by-two comparisons, respectively. Concentration–response relationships were
assessed by Spearman’s correlation. The threshold of significance was set at 0.05. Statistical
analyses were performed using SPSS for Windows statistical package V. 21.
3. Results
In this study, salivary leucocytes were tested as in vitro model for evaluating nano-
materials genotoxicity. Cells were exposed to three different metal oxide NPs, and DNA
damage induction, both primary and oxidative, was investigated by means of comet
assay-based methodologies. The possible interference of the NPs with the comet assay
procedure and hOGG1 enzyme activity was checked prior the experiments. Frozen cells
were used since a recent study demonstrated that cryopreserved salivary leucocytes show
similar sensitivity to DNA damage induction by genotoxic agents than fresh cells and,
consequently, both can be equally employed as appropriate biomatrices to detect DNA
damage by the comet assay [14].
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3.1. Nanoparticle Characterization
Table 1 summarizes the main physical–chemical properties of the NPs tested, namely
size, hydrodynamic diameter, and zeta potential, suspended in water and in leucocyte
culture medium. The size distribution graphs obtained showed a good dispersion of the
NPs in all cases (data not shown). Slightly higher values of the mean hydrodynamic
diameter were observed in culture medium than in aqueous suspensions for TiO2 and
CeO2 NPs, but the value obtained in medium for ZnO NPs was notably lower than the one
in water. On the contrary, values of zeta potential were negative and lower (in absolute
value) in medium than in water, except for CeO2 NPs, that showed a mildly lower positive
value in water.





(nm) b (DLS) Zeta Potential (mV)
b (LDV)
Water Medium Water Medium
TiO2 25 (TEM) 199.1 ± 2.6 264.7 ± 28.2 22.8 ± 3.5 −10.6 ± 0.4
ZnO 100 (BET) 485.6 ± 26.3 199.1 ± 37.8 14.4 ± 1.7 −10.7 ± 0.7
CeO2 18 (BET) 175.3 ± 10.2 197.9 ± 69.4 9.9 ± 2.5 −10.4 ± 0.9
BET: Brunauer–Emmett–Teller; DLS: dynamic light scattering; LDV: laser Doppler velocimetry; TEM: transmission
electronic microscopy. a Provided by the commercial supplier, b mean ± standard deviation.
3.2. Primary DNA Damage
In order to avoid false positive results in the genotoxicity assessment due to cytotoxic-
ity, cell viability was evaluated after NPs treatments. Values obtained for the highest NPs
concentrations tested were always higher than 80% (86.0± 2.0% for TiO2 NPs, 84.84 ± 2.9%
for ZnO NPs, and 86.7 ± 2.2% for CeO2 NPs).
Before conducting the standard alkaline comet assay experiments, the potential in-
terference of NPs with this methodology, including alterations of DNA migration during
electrophoresis, either by inducing breaks into the naked DNA or inhibiting DNA migra-
tion, was assessed. No significant differences in DNA breaks were observed between cells
in the presence of the different NPs, added to the agarose just before preparing the gels, and
cells in the absence of NPs (Figure 1). These results indicate that the presence of NPs did
not interfere with the normal development of the assay and the DNA damage detection.
Figure 1. Assessment of NPs interference with the comet assay methodology. Columns represent
mean values and error bars indicate the standard errors. PC: positive control (50 µg/mL MMS for
3 h). * p < 0.01, significant difference with regard to without NPs.
Leucocytes were then exposed to the three NPs, and alkaline comet assay was con-
ducted; results are depicted in Figure 2. Significant increases in DNA damage with regard
to the negative control were obtained in all treatments tested, with concentration-dependent
increasing trends for all NPs (TiO2 NPs: r = 0.953; p < 0.01; ZnO NPs: r = 0.969; p < 0.01;
CeO2 NPs: r = 0.926; p < 0.01).
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Figure 2. Results of primary DNA damage induced in salivary leucocytes exposed to TiO2, ZnO and CeO2 NPs. PC: positive
control (50 µg/mL MMS for 3 h). Columns represent mean values and error bars indicate the standard errors. * p < 0.01,
significant difference with regard to the negative control.
3.3. Oxidative DNA Damage
Prior to addressing oxidative DNA damage induction by the studied NPs, the possible
interference of these NPs with the hOGG1 enzyme activity was also assessed (Figure 3).
The net hOGG1-sensitive sites observed in cells treated with KBrO3 in the presence of the
different NPs was significantly increased with regard to the negative control, similarly to
what occurred with cells treated with just KBrO3. These data demonstrate that hOGG1
enzyme in the presence of the NPs is still able to detect the oxidative DNA damage induced
by KBrO3, proving that NPs presence did not interfere with the ability of hOGG1 to
effectively detect oxidized DNA bases.
Figure 3. Assessment of NPs interference with hOGG1 enzyme activity. Columns represent mean
values and error bars indicate the standard errors. * p < 0.01, significant difference with regard to
the control.
Results obtained in the evaluation of oxidative DNA damage induced by the three
different NPs are represented in Figure 4. All treatments showed values of net hOGG1-
sensitive sites significantly increased with regard to the control, and significant concentration–
response relationships were also observed (TiO2 NPs: r = 0.921; p < 0.01; ZnO NPs: r = 0.738;
p < 0.01; CeO2 NPs: r = 0.883; p < 0.01).
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Figure 4. Results of oxidative DNA damage induced in salivary leucocytes exposed to TiO2, ZnO and CeO2 NPs. PC:
positive control (335 µg/mL KBrO3 for 1 h). Columns represent mean values and error bars indicate the standard errors.
* p < 0.01, significant difference with regard to the control.
4. Discussion
As with all emerging technologies, the benefits of nanotechnology must be weighed
against potential health and environmental hazards associated with their development,
use and disposal. Engineered nanomaterials are used in a constantly increasing number of
consumer products [22], where they may enhance strength, reactivity and durability, or
provide entirely new functions. However, the development of methods to evaluate the
safe use of nanomaterials and assess potential associated risks has not kept pace with their
rapid commercialization [23]. Due to that, these emerging anthropogenic pollutants have
increasingly become a matter of public concern on the possible impact they might have on
both human health and environment.
Since the available data on nanomaterials environmental and human exposure and
associated toxicity are unfortunately limited, they do not generally allow for significant
quantitative risk assessment of the newly synthesized nanomaterials. Moreover, the prob-
lem of the lack of data becomes even more complicated by the questionable suitability of
the toxicity tests [11]. On this regard, in recent years, some work has focused on the use of
cause-and-effect analysis to systematically describe key sources of variability for in vitro
nanobioassays, including the comet assay, to support method standardization [24]. Thus,
a range of potential biases or artifacts were identified in the comet assay when used for
testing nanomaterials, and the use of positive reference standards, and conducting control
measurements to evaluate the extent of nanomaterial interference with the assay protocol
(including those performed in the current study) were encouraged.
The three metal oxide NPs that were evaluated in this study are relevant nanomaterial
types produced in high tonnage and of widespread use in a number of consumer prod-
ucts [25]. TiO2 NPs are one of the most widely extended engineered nanomaterials. They
are largely used in a variety of industrial and medical applications including cosmetics,
sunscreens, paper products, plastics, paints, drugs, and medical orthopaedic implants.
They are also one of the most profusely studied nanomaterials in terms of toxicity. Due
to the strong evidence collected on their harmful potential, they were classified a decade
ago as human carcinogen (Category 2B) by the International Agency for Research on Can-
cer [26], and a very recent European Food Safety Authority report considered TiO2 NPs no
longer safe when used as a food additive [27].
ZnO NPs are broadly used in various applications including cosmetics, paints, textiles,
as drug carriers and fillings in medical materials [28]. Due to their good absorptive and
photocatalytic properties, these metal oxide NPs are also a good option to be employed in
environmental remediation for elimination or degradation of pollutants in air or water [29].
Consequently, ZnO NPs are among the most used nanomaterials. It is well-accepted that
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ZnO NPs are toxic to mammalian cells in vitro and to the human lung in vivo; still, their
mechanism of toxicity is improperly understood [25].
CeO2 NPs have also a number of applications. They are widely employed in cata-
lysts, fuel additives and polishing agents, and as UV inhibitors on outdoor surfaces [30].
Despite the high commercial interest of these NPs, their effects on human health and the
environment are not completely known and studies conducted on this topic often report
conflicting results [31]. Indeed, their potential toxicity is the less addressed out of the three
NPs of the present study. Due to this lack of information on their potential harmful effects,
the European Agency for Safety and Health at Work has recently listed CeO2 NPs in the
top five nanomaterials worthy of investigation as a priority [32].
Large amounts of these three NPs are released to the environment as a consequence
of their widespread uses; however, their health effects are not completely identified and
the potential risks associated with their exposure cannot be ruled out. Since the inhalation
pathway represents the main route involved in xenobiotic systemic uptake when any type
of NPs are dispersed in air, salivary leucocytes seem to be a suited biomatrix to in vitro
simulate and evaluate genotoxic effects of environmental or occupational exposure to NPs.
They are also easy to obtain, cost-effective, and can be collected non-invasively without
requiring highly trained personnel [14]. Still, to date, they have not been used before in
assessing in vitro nanotoxicity.
Physical–chemical characterization of the NPs showed that nanosized particles were
successfully dispersed in leucocyte culture medium. In addition, TiO2 and CeO2 NPs size
slightly increased when the NPs were dispersed in medium in comparison with water,
probably due to the formation of a protein corona. On the contrary, ZnO NPs hydrodynamic
size resulted considerably higher in water, suggesting a higher tendency to agglomeration
in this fluid rather than in cell culture medium. Zeta potential analyses by LDV showed
more negative values for the three NPs dispersed in medium than in water, agreeing
with previous results in CeO2 [33,34], ZnO [16] and TiO2 [35] NPs, and suggesting that
upon dispersion in the medium, serum proteins are partially adsorbed to the surface of
the particles.
It has been recently demonstrated that the most widespread toxicological tests com-
monly used to assess the possible harmfulness of different chemical agents are not fully
adequate to be applied to nanomaterials [36,37]. This is mainly due to the fact that their
unique physicochemical characteristics may be also responsible for unexpected interactions
with test components or detection systems of standard toxicity tests. In the particular
case of the comet assay, it was previously reported that a mechanism for nanomaterials
interference with the alkaline protocol, involving association to nucleoid DNA, may induce
breakings in the naked DNA or affect its behavior during electrophoresis [21,38]. Con-
sequently, during the lysis step of the comet assay, nanomaterials may interact with the
unprotected DNA and cause additional damage in this macromolecule, interfering with the
sensitivity of the assay and thus misleading the results. However, there is still no validated
protocol for the comet assay to be applied in in vitro nanogenotoxicity evaluation. Similarly,
measurement of oxidative DNA damage in cells exposed to NPs could be altered due to
interactions with the DNA repair enzymes employed for specifically inducing breaks in
oxidized DNA bases [39]. For these reasons, possible interferences of the tested NPs with
the comet assay procedures, both standard and hOGG1-modified, were checked prior
evaluating potential nanogenotoxicity of these NPs. Results obtained from these analyses
showed no interference of the TiO2, ZnO and CeO2 NPs with the standard alkaline comet
assay in any case, discarding any alterations of DNA migration during electrophoresis,
either by inducing additional breaks into the naked DNA or inhibiting DNA migration,
due to the presence of these NPs. Similarly, no interference with the ability of the hOGG1
enzyme to efficiently detect oxidative DNA damage was observed for any tested NPs.
Data on possible NPs interactions with the comet assay procedure are very limited, and
just a previous study from our group addressed the possible interference between NPs
and hOGG1 enzyme, finding interference at the highest concentration of oleic acid-coated
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iron oxide (Fe3O4) NPs tested (200 µg/mL) in SH-SY5Y serum-free culture medium [40].
Magdolenova et al. [21] tested the possible interference of five different NPs, namely Fe3O4
(both oleic acid-coated and uncoated), polylactic-co-glycolic acid, TiO2 and SiO2 NPs,
on standard comet assay results, and found that only oleic acid-coated Fe3O4 induced a
marked level of DNA damage, demonstrating the presence of interference, agreeing with
our findings that TiO2 NPs do not interfere with the assay. Regarding the possible influence
of metal oxide NPs on the activity of DNA glycosylases, Magdolenova et al. [21] found no
interference of silica (SiO2) NPs on formamidopyrimidine DNA glycosylase (FPG) activity.
However, Kain et al. [39] reported that the presence of CeO2 and Co3O4 NPs may influence
the activity of FPG, underestimating the measurement of oxidatively damaged DNA in
A549 and BEAS-2B cells exposed to these NPs.
Once interference was shown not to occur, the standard comet assay protocol was
carried out to evaluate the suitability of salivary leucocytes to detect the potential primary
DNA damage induced by the study NPs. Significant dose–response increases in genetic
damage were found in the three cases. To the best of our knowledge, this is the first
study in which nanogenotoxicity is addressed using leucocytes collected from salivary
samples as in vitro cell model. Nevertheless, there is a number of previous studies in the
literature describing similar genotoxic effects to the ones described here, in different cell
types, by employing the standard alkaline comet assay, corroborating the appropriateness
of salivary leucocytes for nanogenotoxicity assessment. Some examples include BEAS-2B
cells [41], A549 cells [42], SH-SY5Y cells [17] or human lymphocytes [43] treated with
TiO2 NPs, and HEK293 [44], NIH/3T3 [44], A375 [45] and SH-SY5Y [16] cells exposed
to ZnO NPs. In the case of CeO2 NPs, the literature shows certain controversy on their
potential genotoxicity. Previous studies generally demonstrated that doses higher than
those employed in the present study, i.e., 40, 80 or even 200 µg/mL depending on the cell
type, are required to observe genotoxic effects evaluated by the comet assay on cell lines
exposed to these NPs [33,39,46]. However, similarly to our findings, Auffan et al. [47] and
Könen-Adıgüzel and Ergene [48] obtained dose-dependent increases of DNA damage at
very low doses of CeO2 NPs employing human dermal fibroblasts and peripheral blood
leucocytes, respectively, treated in vitro. With regard to the oxidative DNA damage, the
positive responses observed in the current experiments for the three tested NPs are in
agreement with previous studies employing FPG- or hOGG1-modified comet assays for
evaluating TiO2 NPs [17,49,50], ZnO NPs [16,19], and CeO2 NPs [49]. On the contrary,
other studies reported no primary DNA damage [51,52] or oxidative DNA damage [19,53]
after exposure to these specific NPs. This could be due to the different exposure conditions
or sensitivity of the cell type tested, since these parameters are well-known to be highly
relevant in the genotoxicity profile of nanomaterials [54,55]. However, as previously
indicated, most of these studies did not discard possible interference of NPs with the
comet assay procedures, which should also be considered in the interpretation of the
results obtained. According to our data, salivary leucocytes respond to even low CeO2
NPS concentrations, making them a valuable tool in low exposure assessments, probably
consistent with real human exposure scenarios.
Future work on this topic should include quantifying NP dissolution in the cell culture
medium, to determine the possible role of the released ions on the observed genotoxicity,
and comparing among the different types of leucocytes, to evaluate potential differences in
their sensitivity to NP induced effects.
5. Conclusions
Agreeing with other previous studies employing a number of different cell types,
results obtained in this work showed an increase of both primary and oxidative damage
induced by TiO2, ZnO and CeO2 NPs. These data support the use of salivary leucocytes
as a proper and sensitive biological sample for in vitro nanogenotoxicity studies, as well
as reinforce the importance of testing the suitability of standard toxicology protocols for
risk assessment of nanomaterials exposure. Moreover, our data contribute to increase
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the knowledge on the impact of metal oxide NPs on human health, as well as support
the need of a proper regulation of the use of nanomaterials in consumer products and
biomedical applications.
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